Deficits in Monocyte Function in Age Related Macular Degeneration: A Novel Systemic Change Associated With the

Ben J Gu1,2, Xin Huang1, Pavan K Avula1

  • 1The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.

Frontiers in Medicine
|April 5, 2021
PubMed

Insights

Defective peripheral blood monocyte phagocytic function is linked to age-related macular degeneration (AMD). Glatiramer acetate treatment improved monocyte phagocytosis in AMD patients, suggesting a new therapeutic target.

Area of Science:

  • Ophthalmology
  • Immunology
  • Cell Biology

Background:

  • Age-related macular degeneration (AMD) involves debris accumulation in the posterior eye.
  • Systemic immune cell function may play a role in AMD pathogenesis.

Purpose of the Study:

  • To evaluate peripheral blood monocyte phagocytic function in AMD patients.
  • To investigate the effect of glatiramer acetate on monocyte phagocytosis in AMD.

Main Methods:

  • Real-time tri-color flow cytometry was used to quantify phagocytic function.
  • Monocyte subsets (non-classic, intermediate, classic) were analyzed from AMD patients and healthy controls.
  • Phagocytic function was assessed in relation to drusen load and glatiramer acetate treatment.

Main Results:

  • Phagocytic function was reduced in all AMD patients, regardless of disease stage.
  • No correlation was found between phagocytic function and drusen load.
  • Glatiramer acetate treatment enhanced phagocytosis in classical and non-classical monocytes, normalizing levels in AMD patients.

Conclusions:

  • Defective systemic phagocytosis is associated with intermediate and late-stage AMD.
  • Peripheral monocyte phagocytic function offers insights into AMD etiology.
  • Modulating monocyte phagocytosis presents a potential therapeutic strategy for AMD.

Related Concept Videos